Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioadaptives (BDPT) Return on Capital Employed (2019 - 2025)

Bioadaptives' Return on Capital Employed history spans 7 years, with the latest figure at 0.81% for Q3 2025.

  • For Q3 2025, Return on Capital Employed rose 63.0% year-over-year to 0.81%; the TTM value through Sep 2025 reached 0.81%, up 63.0%, while the annual FY2024 figure was 0.39%, 25.0% up from the prior year.
  • Return on Capital Employed for Q3 2025 was 0.81% at Bioadaptives, roughly flat from 0.81% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.81% in Q3 2025 and bottomed at 0.11% in Q2 2023.
  • The 5-year median for Return on Capital Employed is 0.3% (2021), against an average of 0.35%.
  • The largest annual shift saw Return on Capital Employed crashed -34bps in 2023 before it skyrocketed 66bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.59% in 2021, then tumbled by -51bps to 0.29% in 2022, then tumbled by -49bps to 0.15% in 2023, then surged by 157bps to 0.38% in 2024, then skyrocketed by 112bps to 0.81% in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Return on Capital Employed are 0.81% (Q3 2025), 0.81% (Q2 2025), and 0.54% (Q1 2025).